Nasal spray version of common diuretic has potential to help treat heart failure
November 18, 2024
November 18, 2024
DALLAS, Texas, Nov. 18 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation) in healthy adults in comparison to the oral and intravenous forms of the medication. The existing oral and intravenous forms of bumetanide are com . . .
Research Highlights:
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation) in healthy adults in comparison to the oral and intravenous forms of the medication. The existing oral and intravenous forms of bumetanide are com . . .